COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study - 10/04/21
Doi : 10.1016/j.jaad.2021.02.013
Maria Gonzalez-Cao, MD, PhD a, ⁎ 
, Cristina Carrera, MD b, Juan Francisco Rodriguez Moreno, MD c, Pedro Rodríguez-Jiménez, MD d, Mónica Antoñanzas Basa, MD e, Rosa Feltes Ochoa, MD f, Teresa Puertolas, MD g, Eva Muñoz-Couselo, MD h, i, José Luis Manzano, MD j, Ivan Marquez-Rodas, MD k, Juan Martín-Liberal, MD l, Ainara Soria, MD m, Pilar Lopez Criado, MD n, Almudena Garcia-Castaño, MD o, Aram Boada, MD p, Pablo Ayala de Miguel, MD q, Susana Puig, MD b, Guillermo Crespo, MD r, Pablo Luna Fra, MD s, Cristina Aguayo Zamora, MD t, Marta Feito Rodríguez, MD f, Lara Valles, MD u, Ana Drozdowskyj, PhD a, Cayetana Maldonado-Seral, MD v, Jesús Gardeazabal, MD w, Laura Villalobos, MD x, Rafael Rosell, MD a, y, Luis Antonio Fernandez-Morales, MD z, Alberto Rodrigo, MD aa, Santiago Viteri, MD a, Mariano Provencio, MD bb, Alfonso Berrocal, MD cc
for the
, Cristina Carrera, MD b, Juan Francisco Rodriguez Moreno, MD c, Pedro Rodríguez-Jiménez, MD d, Mónica Antoñanzas Basa, MD e, Rosa Feltes Ochoa, MD f, Teresa Puertolas, MD g, Eva Muñoz-Couselo, MD h, i, José Luis Manzano, MD j, Ivan Marquez-Rodas, MD k, Juan Martín-Liberal, MD l, Ainara Soria, MD m, Pilar Lopez Criado, MD n, Almudena Garcia-Castaño, MD o, Aram Boada, MD p, Pablo Ayala de Miguel, MD q, Susana Puig, MD b, Guillermo Crespo, MD r, Pablo Luna Fra, MD s, Cristina Aguayo Zamora, MD t, Marta Feito Rodríguez, MD f, Lara Valles, MD u, Ana Drozdowskyj, PhD a, Cayetana Maldonado-Seral, MD v, Jesús Gardeazabal, MD w, Laura Villalobos, MD x, Rafael Rosell, MD a, y, Luis Antonio Fernandez-Morales, MD z, Alberto Rodrigo, MD aa, Santiago Viteri, MD a, Mariano Provencio, MD bb, Alfonso Berrocal, MD ccfor the
Spanish Melanoma Group (GEM)
a Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain
b Dermatology Department, Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain
c Medical Oncology Department, Centro Integral Oncologico HM Clara Campal, Madrid, Spain
d Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain
e Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain
f Hospital Universitario La Paz, Madrid, Spain
g Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain
h Medical Oncology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
i Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
j Catalonian Institute of Oncology (ICO-Badalona), Medical Oncology Department, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain
k Medical Oncology Department, Hospital General Universitario Gregorio Marañon and CIBERONC, Madrid, Spain
l Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain
m Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain
n Medical Oncology Department, Hospital MD Anderson, Madrid, Spain
o Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain
p Dermatology Department, Hospital Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain
q Medical Oncology Department, Hospital San Pedro de Alcántara, Cáceres, Spain
r Medical Oncology Department, Hospital Universitario de Burgos, Burgos, Spain
s Medical Oncology Department, Hospital Son Espases, Mallorca, Spain
t Medical Oncology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
u Medical Oncology Department, Hospital General de Villalba, Madrid, Spain
v Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
w Medical Oncology Department, Hospital de Cruces, Bizkaya, Spain
x Medical Oncology Department, Hospital Principe de Asturias, Alcala de Henares, Spain
y Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain
z Medical Oncology Department, Hospital Parc Tauli, Sabadell, Spain
aa Medical Oncology Department, Hospital Arnau de Vilanova, Lleida, Spain
bb Medical Oncology Department, Hospital Puerta de Hierro, Madrid, Spain
cc Medical Oncology Department, Hospital Universitario General de Valencia, Valencia, Spain
∗Correspondence to: Maria Gonzalez-Cao, MD, PhD, Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028 Barcelona, SpainTranslational Cancer Research UnitInstituto Oncologico Dr RosellDexeus University HospitalC/Sabino Arana, 5Barcelona080028Spain
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: This study has been funded by Spanish Melanoma Group. It has not been sponsored by any pharmaceutical company. |
|
| IRB approval status: Reviewed and approved by the Ethics Committee of the Hospital Puerta del Hierro, Madrid (Exp. 6/2020). |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 5
P. 1412-1415 - mai 2021 Retour au numéro
Article précédent
- Seroconversion of severe acute respiratory syndrome coronavirus 2–infected patients on immunosuppression: A retrospective analysis
- Jeffrey S. Smith, Jordan T. Said, Scott A. Elman, Claire E.P. Smith, Joseph F. Merola
- Fitzpatrick phototype disparities in identification of cutaneous malignancies by Google Reverse Image
- Justin L. Jia, Jennifer Y. Wang, Dawson E. Mills, Andrew Shen, Kavita Y. Sarin
Bienvenue sur EM-consulte, la référence des professionnels de santé.